sRNAs, miRNAs Could One Day Change Therapeutics Landscape
A decade ago, the actions of small RNAs (sRNAs) and microRNAs (miRNAs) were not on the radar screen of biology. Now, understanding how these work and even modulating them could dramatically advance the delivery of therapeutics.
Read More...
Transplant centers do not suddenly get in trouble with the Organ Procurement and Transplantation Network (OPTN) because of data reported from the Scientific Registry of Transplant Recipients (SRTR). Instead, it takes years for transplant programs to reach that problematic state.
Read More...
Today's work at the bench in transforming skin cells into stem cells presents exciting potential for the field of transplantation to reverse inherited diseases. Learn the current status of this new reprogramming technology from cell biologist Rudolf Jaenisch, MD, when he presents the State-of-the-Art Address on "Stem Cells and the Molecular Control of Pluripotency for Regenerative Medicine" at 10 a.m. today in the Auditorium of the Hynes Convention Center.
Read More...
The Food and Drug Administration (FDA) approved the use of tacrolimus with mycophenolate mofetil (MMF) on May 19 to help combat organ rejection in kidney transplant recipients. The effect of the approval of this drug regimen is expected to be discussed in a session Tuesday.
Read More...
The use of T cells to regulate immune responses in transplanted grafts will be discussed in three presentations from 11:00 am – 12:30 pm Tuesday during the Mid-day Symposium, "Cutting Edge Topics in Transplantation: Regulation of the Immune Response" in the Auditorium of Hynes Convention Center.
Read More...
Mesenchymal stem cells (MSCs) are known to generate new tissue, but new research shows they can also regulate immune response, a development that will be examined in a symposium from 11:00 am – 12:30 pm Monday in Ballroom A of the Hynes Convention Center.
Read More...
A pilot study on withdrawing immunosuppression in pediatric liver transplant recipients and surveys on nucleic acid testing in high-risk donors will be among top abstracts at Plenary Session II from 8:30 – 10:00 am today in the Auditorium of the Hynes Convention Center.
Read More...
The American Society of Transplantation (AST) will hold its first Annual Scientific Exchange (ASE) Dec. 3-6, 2009, at the Marriott World Center in Orlando, Fla. Given the novel format and focus of the meeting, AST is confident that this first-of-its-kind conference will become the key scientific meeting in the field of transplantation. ASE will allow new and established researchers in basic, translational and clinical transplantation to present their research in a relaxed yet focused forum designed to optimize the exchange of scientific information.
Read More...
The AST Public Policy Committee and the Society's government relations office have enjoyed one of the most active and successful years in the history of the organization.
Read More...
2009 AST/Roche Ernest Hodge Distinguished Achievement Award
John Curtis, MD
2009 AST President's Award
A. Benedict Cosimi, MD
Read More...
Thank You to AST Corporate Sponsors
The American Society of Transplantation is extremely grateful to the following companies for their support of AST's many educational activities.
Read More...
At the forefront of the American Society of Transplant Surgeons (ASTS) is its responsibility and commitment to the educational endeavors that help propel transplantation. ASTS has a rich history of providing a plethora of educational programs to the junior, intermediate and senior surgeon, physician, researcher, physician assistant, nurse practitioner and other transplant professionals. Offering over two dozen programs and initiatives, the ASTS is an important Society for those dedicated to advancing the practice and science of transplantation.
Read More...
The American Society of Transplant Surgeons (ASTS), a non-profit organization, was founded in 1974 to foster and advance the practice and science of transplantation for the benefits of patients and society. ASTS is the only organization in America principally devoted to issues that affect transplant surgeons, their institutions, and the patients whom they serve. The majority of members are board certified surgeons with additional training in transplantation and a record of publications in peer reviewed journals. At the core of the ASTS mission is a commitment to defining and promoting training and the career-long education of its members.
Read More...
The American Society of Transplant Surgeons would like to thank the following companies for their generous support of the ASTS in 2009.
Read More...